|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2005-4-7
|
|
pubmed:abstractText |
Previous trials have demonstrated that lowering low-density lipoprotein (LDL) cholesterol levels below currently recommended levels is beneficial in patients with acute coronary syndromes. We prospectively assessed the efficacy and safety of lowering LDL cholesterol levels below 100 mg per deciliter (2.6 mmol per liter) in patients with stable coronary heart disease (CHD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BarterPhilipP,
pubmed-author:FruchartJean-CharlesJC,
pubmed-author:GretenHeinerH,
pubmed-author:GrundyScott MSM,
pubmed-author:KasteleinJohn J PJJ,
pubmed-author:LaRosaJohn CJC,
pubmed-author:ShearCharlesC,
pubmed-author:ShepherdJamesJ,
pubmed-author:SiE CEC,
pubmed-author:Treating to New Targets (TNT) Investigators,
pubmed-author:WatersDavid DDD,
pubmed-author:WengerNanette KNK
|
|
pubmed:copyrightInfo |
Copyright 2005 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
7
|
|
pubmed:volume |
352
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1425-35
|
|
pubmed:dateRevised |
2006-12-7
|
|
pubmed:meshHeading |
pubmed-meshheading:15755765-Adult,
pubmed-meshheading:15755765-Aged,
pubmed-meshheading:15755765-Alanine Transaminase,
pubmed-meshheading:15755765-Anticholesteremic Agents,
pubmed-meshheading:15755765-Cardiovascular Diseases,
pubmed-meshheading:15755765-Cholesterol,
pubmed-meshheading:15755765-Cholesterol, LDL,
pubmed-meshheading:15755765-Coronary Disease,
pubmed-meshheading:15755765-Dose-Response Relationship, Drug,
pubmed-meshheading:15755765-Female,
pubmed-meshheading:15755765-Heptanoic Acids,
pubmed-meshheading:15755765-Humans,
pubmed-meshheading:15755765-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15755765-Incidence,
pubmed-meshheading:15755765-Male,
pubmed-meshheading:15755765-Middle Aged,
pubmed-meshheading:15755765-Prospective Studies,
pubmed-meshheading:15755765-Pyrroles,
pubmed-meshheading:15755765-Risk,
pubmed-meshheading:15755765-Triglycerides
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
|
|
pubmed:affiliation |
State University of New York Health Science Center, Brooklyn, NY 11203, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
